Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 24th:

Apellis Pharmaceuticals, Inc. : This commercial-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.1% over the last 60 days.

Apellis Pharmaceuticals, Inc. Price and Consensus

Apellis Pharmaceuticals, Inc. price-consensus-chart | Apellis Pharmaceuticals, Inc. Quote

Apellis’ shares gained 50.3% over the last three months compared with the S&P 500’s decline of 6.8%. The company possesses a Momentum Score  of A.

Apellis Pharmaceuticals, Inc. Price

Apellis Pharmaceuticals, Inc. price | Apellis Pharmaceuticals, Inc. Quote

Groupon, Inc. (GRPN Quick QuoteGRPN - Free Report) : This marketplace which connects consumers to merchants has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.9% over the last 60 days.

Groupon, Inc. Price and Consensus

Groupon, Inc. price-consensus-chart | Groupon, Inc. Quote

Groupon’s shares gained 67.3% over the last three months compared with the S&P 500’s decline of 6.8%. The company possesses a Momentum Score of B.

Groupon, Inc. Price

Groupon, Inc. price | Groupon, Inc. Quote

Central Garden & Pet Company (CENTA Quick QuoteCENTA - Free Report) : This gardening and pet supply company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its next year earnings increasing 1.4% over the last 60 days.

Central Garden & Pet Company Price and Consensus

Central Garden & Pet Company price-consensus-chart | Central Garden & Pet Company Quote

Central Garden’s shares gained 3.6% over the last three months compared with the S&P 500’s decline of 6.8%. The company possesses a Momentum Score of B.

Central Garden & Pet Company Price

Central Garden & Pet Company price | Central Garden & Pet Company Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.